Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease

The global incidence rate of non-alcoholic fatty liver disease (NAFLD) is approximately 25%. With the global increase in obesity and its associated metabolic syndromes, NAFLD has become an important cause of chronic liver disease in many countries. Despite recent advances in pathogenesis, diagnosis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yajie, Zhou, Yanzhi, Shen, Linhu, Li, Xuewen, Zhang, Haorui, Cui, Yeqi, Zhang, Ke, Li, Weiguo, Chen, Wei-dong, Zhao, Shizhen, Li, Yunfu, Ye, Wenling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666875/
https://www.ncbi.nlm.nih.gov/pubmed/36408234
http://dx.doi.org/10.3389/fphar.2022.973366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666875/
https://www.ncbi.nlm.nih.gov/pubmed/36408234
http://dx.doi.org/10.3389/fphar.2022.973366

Ejemplares similares